August 4, 2026
Beyond the transplant list: the pediatric cardiomyopathy pipeline finally has momentum
Dilated cardiomyopathy (DCM) is the most common form of cardiomyopathy in children and the leading reason kids end up on…
Pharmaceuticals, Biotechnology and Life Sciences
Category: My Pharmaceutical
March 13, 2026
BioCardia’s cell therapy may help the failing heart stop working against itself
Phase III echocardiography data presented at THT 2026 suggest a targeted cellular approach may do what drugs alone cannot for a specific population of ischemic heart failure patients
March 11, 2026
Light instead of antibiotics: Ondine’s Phase 3 trial is weeks away from results that could reshape surgical infection prevention
A five-minute pre-surgical procedure using light is about to face its biggest test — and the clinical trial metrics, according to the company, are unusually clean.
February 27, 2026
AI and job cuts: What the block layoffs signal for pharma and beyond
In the past few months, the corporate world has seen a surge in workforce reductions that are explicitly tied to artificial intelligence (AI) and automation — not just general cost-cutting. The biggest recent example comes from fintech firm Block Inc., which announced plans to cut over 4,000 jobs — roughly 40 % of its workforce — as AI tools reshape how it builds and runs its business, according to multiple news reports. What about pharma?
February 26, 2026
The ADC arms race: payload power vs targeting precision
Over the past decade, antibody-drug conjugates (ADCs) have emerged as a high-impact class of cancer therapies, blending the selectivity of antibodies with the potency of cytotoxic payloads. But as the modality matures, a structural tension is becoming clear: should innovation focus on chemical escalation of payloads and linkers, or on biological precision of target engagement?
February 25, 2026
Bispecific ADCs: are dual-target ‘AND-Gate’ designs the future of tumour selectivity?
Antibody-drug conjugates (ADCs) continue to evolve as one of the most promising approaches in targeted cancer therapy, yet the fundamental…
December 11, 2024
Women urged to put breast density knowledge at the top of their Christmas list
Micrima, a Bristol-based health tech company, is urging women to give themselves the gift of prioritising knowledge of their breast…
October 18, 2024
Brenntag celebrates the company’s 150th anniversary in Essen, Germany
Brenntag, the global market leader in chemicals and ingredients distribution, held a celebration to mark its 150-year anniversary yesterday in Essen, Germany, where the DAX40 company is headquartered.
October 18, 2024
Over-65s to benefit from potentially life-changing new treatment options thanks to technology-powered clinical trials initiative from Cera
Over-65s across the UK are set to benefit from potentially life-changing new treatment options for conditions like cancer and cardiovascular disease, thanks to an innovative new clinical trials initiative from healthtech company Cera.
September 25, 2024
SLEEVER and CARBIOS globally launch world’s first Home Compost biodegradable tamper evident seal: SEELCAP ONEGO
SLEEVER®, a French family-owned group International SME and innovative leader in shrinksleeve label technology, and CARBIOS, (Euronext Growth Paris : ALCRB), a pioneer in the…